GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
2I6S | P06681 | Complement component C2a | |
2ODP | P06681 | Complement component C2a, the catalytic fragment of C3- and C5-convertase of human complement | |
2ODQ | P06681 | Complement component C2a, the catalytic fragment of C3- and C5-convertase of human complement | |
8ACF | P06681 | Structure of the argX-117 in complex with a complement C2 fragment at low pH | |
8ACI | P06681 | Structure of ARG-117 Fab in complex with a fragment of complement C2, neutral pH | |
6CXO | P06683 | Complement component-9 | Complement component C9 |
1LT3 | P06717 | HEAT-LABILE ENTEROTOXIN DOUBLE MUTANT N40C/G166C | |
1LT4 | P06717 | HEAT-LABILE ENTEROTOXIN MUTANT S63K | |
1LTA | P06717 | 2.2 ANGSTROMS CRYSTAL STRUCTURE OF E. COLI HEAT-LABILE ENTEROTOXIN (LT) WITH BOUND GALACTOSE | HEAT-LABILE ENTEROTOXIN (LT) COMPLEX WITH GALACTOSE |
1LTI | P06717 | HEAT-LABILE ENTEROTOXIN (LT-I) COMPLEX WITH T-ANTIGEN | HEAT LABILE ENTEROTOXIN TYPE I |
1LTT | P06717 | LACTOSE BINDING TO HEAT-LABILE ENTEROTOXIN REVEALED BY X-RAY CRYSTALLOGRAPHY | HEAT-LABILE ENTEROTOXIN (LT) COMPLEX WITH LACTOSE |
7T6I | P06725 | Crystal structure of HLA-DP1 in complex with pp65 peptide in reverse orientation | |
1GYA | P06729 | N-GLYCAN AND POLYPEPTIDE NMR SOLUTION STRUCTURES OF THE ADHESION DOMAIN OF HUMAN CD2 | HUMAN CD2 |
1HNF | P06729 | CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE HUMAN CELL ADHESION MOLECULE CD2 AT 2.5 ANGSTROMS RESOLUTION | CD2 (HUMAN) |
8BW0 | P06731 | Structure of CEACAM5 A3-B3 domain in Complex with Tusamitamab Fab | |
4EZM | P06734 | Crystal structure of the human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23 | |
4GKO | P06734 | Crystal structure of the calcium2+-bound human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23 | |
4KI1 | P06734 | Primitive triclinic crystal form of the human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23 | |
5LGK | P06734 | Crystal structure of the human IgE-Fc bound to its B cell receptor derCD23 | |
1EM6 | P06737 | HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH GLCNAC AND CP-526,423 | HUMAN LIVER GLYCOGEN PHOSPHORYLASE, BIS[5-CHLORO-1H-INDOL-2-YL-CARBONYL-AMINOETHYL]-ETHYLENE GLYCOL, PYRIDOXAL-5'-PHOSPHATE |
1EXV | P06737 | HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH GLCNAC AND CP-403,700 | GLYCOGEN PHOSPHORYLASE, PYRIDOXAL-5'-PHOSPHATE, 1-{2-[5-CHLORO-1H-INDOLE-2-CARBONYL)-AMINO]-3-PHEYNYL-PROPIONYL}-AZETIDINE-3-CARBOXYLIC ACID |
1FA9 | P06737 | HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH AMP | |
1FC0 | P06737 | HUMAN LIVER GLYCOGEN PHOSPHORYLASE COMPLEXED WITH N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE | |
1L5Q | P06737 | Human liver glycogen phosphorylase a complexed with caffeine, N-Acetyl-beta-D-glucopyranosylamine, and CP-403700 | Glycogen phosphorylase, liver form (E.C.2.4.4.1) |
1L5R | P06737 | Human liver glycogen phosphorylase a complexed with riboflavin, N-Acetyl-beta-D-Glucopyranosylamine and CP-403,700 | glycogen phosphorylase, liver form (E.C.2.4.4.1) |
1L5S | P06737 | Human liver glycogen phosphorylase complexed with uric acid, N-Acetyl-beta-D-glucopyranosylamine, and CP-403,700 | Glycogen phosphorylase, liver form (E.C.2.4.4.1) |
1L7X | P06737 | Human liver glycogen phosphorylase b complexed with caffeine, N-acetyl-beta-D-glucopyranosylamine, and CP-403,700 | Glycogen phosphorylase, liver form (E.C.2.4.1.1.) |
1XOI | P06737 | Human Liver Glycogen Phosphorylase A complexed with Chloroindoloyl glycine amide | |
2ATI | P06737 | Glycogen Phosphorylase Inhibitors | Glycogen phosphorylase, liver form (E.C.2.4.1.1) |
2ZB2 | P06737 | Human liver glycogen phosphorylase a complexed with glcose and 5-chloro-N-[4-(1,2-dihydroxyethyl)phenyl]-1H-indole-2-carboxamide | |
3CEH | P06737 | Human liver glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE5688 | Glycogen phosphorylase (E.C.2.4.1.1) |
3CEJ | P06737 | Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE2865 | Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE2865 |
3CEM | P06737 | Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE9423 | Glycogen phosphorylase (E.C.2.4.1.1) |
3DD1 | P06737 | Crystal structure of glycogen phophorylase complexed with an anthranilimide based inhibitor GSK254 | |
3DDS | P06737 | Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK261 | |
3DDW | P06737 | Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK055 | |
6XUH | P06744 | Crystal structure of human phosphoglucose isomerase in complex with inhibitor | |
6XUI | P06744 | Crystal structure of human phosphoglucose isomerase in complex with inhibitor | |
1IRI | P06744 | Crystal structure of human autocrine motility factor complexed with an inhibitor | |
1NUH | P06744 | The crystal structure of human phosphoglucose isomerase complexed with 5-phosphoarabinonate | |
1U0F | P06745 | Crystal structure of mouse phosphoglucose isomerase in complex with glucose 6-phosphate | |
1U0G | P06745 | Crystal structure of mouse phosphoglucose isomerase in complex with erythrose 4-phosphate | |
2CXQ | P06745 | Crystal structure of mouse AMF / S6P complex | |
2CXR | P06745 | Crystal structure of mouse AMF / 6PG complex | |
2CXS | P06745 | Crystal structure of mouse AMF / F6P complex | |
2CXT | P06745 | Crystal structure of mouse AMF / F6P complex | |
1RZO | P06750 | Agglutinin from Ricinus communis with galactoaza | |
6MK0 | P06756 | Integrin AlphaVBeta3 ectodomain bound to antagonist TDI-4161 | |
6DJP | P06756 | Integrin alpha-v beta-8 in complex with the Fabs 8B8 and 68 | Integrin alpha-V, Integrin beta-8, 8B8 heavy chain Fab, 8B8 light chain Fab, 68 heavy chain Fab, 68 light chain Fab |
6OM1 | P06756 | Crystal structure of an atypical integrin |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024